- Home
- ITUB vs PFE Comparison
ITUB vs PFE Comparison
Compare ITUB & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITUB | PFE |
|---|---|---|
| Founded | 1924 | 1849 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7B | 147.6B |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ITUB | PFE |
|---|---|---|
| Price | $7.51 | $28.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $9.00 | ★ $29.29 |
| AVG Volume (30 Days) | 20.7M | ★ 33.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | 6.12% | ★ 6.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $62,579,000,000.00 |
| Revenue This Year | $46.47 | N/A |
| Revenue Next Year | $8.14 | N/A |
| P/E Ratio | ★ $12.60 | $65.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.74 | $23.59 |
| 52 Week High | $9.60 | $28.75 |
Technical Indicators
Market Signals| Indicator | ITUB | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 69.69 |
| Support Level | $7.33 | $24.90 |
| Resistance Level | $8.18 | $28.75 |
| Average True Range (ATR) | 0.21 | 0.54 |
| MACD | -0.03 | 0.16 |
| Stochastic Oscillator | 26.79 | 85.96 |
Price Performance
Historical ComparisonAbout ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio as of the end of 2025. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.